FR2540116B1 - Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique - Google Patents

Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique

Info

Publication number
FR2540116B1
FR2540116B1 FR8401402A FR8401402A FR2540116B1 FR 2540116 B1 FR2540116 B1 FR 2540116B1 FR 8401402 A FR8401402 A FR 8401402A FR 8401402 A FR8401402 A FR 8401402A FR 2540116 B1 FR2540116 B1 FR 2540116B1
Authority
FR
France
Prior art keywords
same
luzopeptin
antitumor
pharmaceutical compositions
novel antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8401402A
Other languages
English (en)
Other versions
FR2540116A1 (fr
Inventor
Charles A Claridge
Henri Schmitz
Terrence W Doyle
Marianne F Kammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2540116A1 publication Critical patent/FR2540116A1/fr
Application granted granted Critical
Publication of FR2540116B1 publication Critical patent/FR2540116B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8401402A 1983-01-31 1984-01-30 Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique Expired FR2540116B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46257783A 1983-01-31 1983-01-31

Publications (2)

Publication Number Publication Date
FR2540116A1 FR2540116A1 (fr) 1984-08-03
FR2540116B1 true FR2540116B1 (fr) 1989-08-18

Family

ID=23836950

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8401402A Expired FR2540116B1 (fr) 1983-01-31 1984-01-30 Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique

Country Status (15)

Country Link
JP (1) JPH0645638B2 (fr)
KR (1) KR880001638B1 (fr)
AU (1) AU566569B2 (fr)
BE (1) BE898807A (fr)
CA (1) CA1220746A (fr)
CH (1) CH663415A5 (fr)
DE (1) DE3403125A1 (fr)
FR (1) FR2540116B1 (fr)
GB (1) GB2134119B (fr)
GR (1) GR81749B (fr)
IT (1) IT1175927B (fr)
MY (1) MY8800015A (fr)
NL (1) NL8400237A (fr)
SE (1) SE464582B (fr)
ZA (1) ZA84613B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2050384B (en) * 1979-04-02 1983-04-07 Bristol Myers Co Antitumor antibacterial agents

Also Published As

Publication number Publication date
DE3403125A1 (de) 1984-10-31
JPS59173091A (ja) 1984-09-29
FR2540116A1 (fr) 1984-08-03
NL8400237A (nl) 1984-08-16
AU566569B2 (en) 1987-10-22
KR880001638B1 (ko) 1988-09-03
IT8419348A0 (it) 1984-01-27
GB8402410D0 (en) 1984-02-29
MY8800015A (en) 1988-12-31
JPH0645638B2 (ja) 1994-06-15
KR840007106A (ko) 1984-12-05
CA1220746A (fr) 1987-04-21
GB2134119B (en) 1986-04-30
CH663415A5 (de) 1987-12-15
SE8400450D0 (sv) 1984-01-30
GB2134119A (en) 1984-08-08
GR81749B (fr) 1984-12-12
BE898807A (fr) 1984-07-31
ZA84613B (en) 1984-09-26
SE464582B (sv) 1991-05-13
SE8400450L (sv) 1984-08-01
IT1175927B (it) 1987-08-12
AU2372184A (en) 1984-08-02

Similar Documents

Publication Publication Date Title
DE3265206D1 (en) Benzazepines, process for their preparation and their application as pharmaceutical preparations
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
HUT36116A (en) Process for producing n,n-piperazinyl- derivatives and pharmaceutical compositions containing them
IL84863A (en) 3-aryloxy-3-substituted propanamines,process for their preparation and pharmaceutical compositions comprising them
PT77488B (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
DE3461090D1 (en) 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
IL82231A (en) 1-hydroxy-2-pyridones,process for their preparation and pharmaceutical compositions which contain them
FR2532648B1 (fr) Derives de carbostyrile, leur procede de preparation et leur application en therapeutique
ZA821020B (en) Azepine derivatives, process for their preparation and pharmaceutical compositions thereof
EP0145121A3 (en) Pyrazoloquinolines, process for their preparation, and pharmaceutical compositions containing them
ZA816826B (en) Pyridine derivatives, processes for their preparation, and pharmaceutical compositions thereof
EP0251453A3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
DE3161238D1 (en) 20-deoxyrosaramicin derivatives, process for their preparation and pharmaceutical compositions containing them
IL69735A (en) 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them
FR2539126B1 (fr) Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant
IL84791A0 (en) Substituted aminopropionamides,process for their preparation and pharmaceutical compositions containing them
FR2526798B1 (fr) Derives de peneme, leur procede de preparation et compositions therapeutiques les contenant
GB2138817B (en) 4-pheny-tetrahydro-furano-pyridines, process for their preparation, and pharmaceutical compositions containing them
FR2540116B1 (fr) Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique
IL82332A (en) Substituted 2-phenylbenzothiazin(-3-)one derivatives,process for their preparation and pharmaceutical compositions containing them
FR2595697B1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
IL64123A (en) Biphenylyloxypropoxypyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
IL62747A0 (en) 2-guanidinothiazole derivatives,process for the preparation thereof and pharmaceutical compositions comprising the same
DE3176402D1 (en) Benzazol derivatives, processes for their preparation, their pharmaceutical composition and their application
DE3365979D1 (en) Beta-lactam antibiotics, process for their preparation and their use as medicines

Legal Events

Date Code Title Description
ST Notification of lapse